The study tests whether a drug called Kineret® can improve recovery following aSAH. This has the potential to make a profound difference in patient outcome.
A great well done to all the neurosurgical units in the UK for recruiting at the highest monthly rate since the trial started. Let's keep up this rate for the remaining three months!!!
Delighted to announce we've randomised not only our first but also our second participant to the SCIL study this week!
Great effort by study lead CRP @terilou_ and research nurse @NorthWestNurse, with brilliant support by @AFAlalade and medical team too.
#SCILSAH